Thursday’s trading session on Wall Street presents a mixed picture, characterized by notable fluctuations in major indices. While tech-heavy benchmarks like the S&P 500 and the Nasdaq 100 are experiencing declines, blue-chip stocks and small caps are treading the path of marginal gains.
Competition and Optimism: GSK’s CEO Walmsley Foresees Growth Despite Competition In RSV Vaccine Market
Yesterday, 2:15 PM
Emma Walmsley, the Chief Executive Officer of GSK plc (NYSE: GSK), expressed confidence in its respiratory syncytial virus (RSV) vaccine, Arexvy, anticipating sales to surpass £1 billio
Yesterday, 12:44 PM
JP Morgan is bearish on the US stock market in 2024, predicting an 8% drop. They point to rich valuations, aging cycle, restrictive monetary policy, geopolitical risks, and rising debt costs as factors that could contribute to the decline.
Yesterday, 12:24 PM
Activist investor Nelson Peltz and his firm, Trian Fund Management, seek more than two seats on the board of entertainment giant Walt Disney & Co (NYSE: DIS), escalating tensions and setting the stage for a
Yesterday, 11:30 AM
AbbVie Inc (NYSE: ABBV) has agreed to acquire ImmunoGen Inc (NASDAQ: IMGN) and its flagship cancer therapy Elahere (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC) approved f
Novo Nordisk Sues Florida Compounding Pharmacies Over Impurities In Products Claiming To Contain Wegovy Ingredient
Yesterday, 11:09 AM
Novo Nordisk A/S (NYSE: NVO) has reportedly taken legal action against Florida compounding pharmacies, suing one and refiling a lawsuit against another, as it discovered impurities in their products claiming to contain the active ingredient, semaglutide, for its popular
Stocks Drift Higher On Stronger GDP Data, Oil Rebounds As OPEC+ Mulls Cuts: What’s Driving Markets Wednesday?
November 29, 2:59 PM
Stocks are experiencing their 16th green session out of the 20 so far in November, with the S&P 500 index reaching its highest level since early August, and the Nasdaq 100 just 4.4% below its all-time highs set in November 2021.
November 29, 2:21 PM
AbbVie Inc (NYSE: ABBV) announced topline results from the single-arm Phase 2 LUMINOSITY trial evaluating telisotuzumab-vedotin (Teliso-V) in patients with c-Met protein overexpression, epidermal growth factor receptor (EGFR) wild type,
November 29, 2:19 PM
The S&P 500 index could return 11% in 2024, analysts predict. DataTrek co-founder Nicholas Colas suggests investing in the Russell 3,000.
November 29, 2:02 PM
Cigna Group (NYSE: CI) and Humana Inc (NYSE: HUM) are reportedly discussing a merger deal to create a new powerhouse in the health insurance industry.